LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has expanded its product portfolio with the release of version 1.0 of its MembranePlus™ simulation software.
Mr. John DiBella, vice president for marketing and sales of Simulations Plus, said, “Simulations Plus continues to expand its product line with frequent release enhancements of our existing line of software products, and now the release of MembranePlus 1.0, our first completely new software product since DDDPlus™ was released about 10 years ago. This new software program is expected to appeal to a wide audience of pharmaceutical companies who use in vitro measurements of molecule permeabilities to estimate the likely permeability in preclinical species as well as humans.”
Help employers find you! Check out all the jobs and post your resume.
